Mia's Feed
Medical News & Research

Childhood Socioeconomic Disadvantage Associated with Brain Changes in Professional Fighters

Childhood Socioeconomic Disadvantage Associated with Brain Changes in Professional Fighters

Share this article

A recent study reveals that professional fighters from socioeconomically disadvantaged backgrounds are more likely to experience early brain changes associated with neurodegeneration, highlighting the impact of childhood environment on long-term brain health.

2 min read

Recent research highlights that professional combat athletes who grow up in socioeconomically disadvantaged neighborhoods may experience greater brain alterations linked to neurodegeneration later in life. The study, published on August 13, 2025, in Neurology Open Access, examined how childhood environment influences brain health among fighters engaged in boxing, mixed martial arts, and similar sports.

The investigation involved 100 active or recently retired professional combat sports athletes, of whom 14% were female, and 43% identified as Black, American Indian/Alaska Native, Asian, Pacific Islander, or from multiple racial backgrounds. All participants had at least ten fights and were followed over an average of five years. During this period, about 20% developed cognitive issues affecting thinking and memory.

Using magnetic resonance imaging (MRI), researchers assessed brain structure periodically. They also evaluated social factors such as income, education, and housing quality, utilizing Census data and the Area Deprivation Index, which assigns higher scores to more disadvantaged neighborhoods. Athletes from areas with high socioeconomic disadvantage primarily showed signs of early neurodegeneration, including a thinner outer brain layer and reduced volumes in key regions such as the thalamus, cerebellar cortex, and hippocampus.

Specifically, the thalamus volume was approximately 354 mm³ smaller in athletes from high-disadvantage backgrounds, and the cerebellar cortex was about 2,478 mm³ smaller compared to those from more privileged areas. Adjusting for elevated levels of neurodegeneration biomarkers indicated that these volume reductions could be as much as 60% lower in the most disadvantaged individuals.

This study emphasizes that brain health is influenced not only by factors like fight history and head impacts but also significantly by social and economic contexts. Stressors associated with poverty, such as poor housing, limited access to healthcare, and economic instability, may compound the risks of brain damage from repetitive head injuries.

However, the study's scope was limited to athletes currently active or recently retired, which might underestimate the long-term effects observed in athletes with longer careers or retired long ago. Nonetheless, these findings underscore the importance of considering socioeconomic factors when addressing neurodegenerative risks in athletes.

Ultimately, the research advocates for a broader perspective in brain health strategies, recognizing that where an individual grows up can impact their resilience against neurodegeneration. By acknowledging these social determinants, more equitable and effective protective measures can be developed for athletes from marginalized communities.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Study Finds Cannabinoid Products May Shorten Sleep Duration in Adults with Insomnia

A recent study reveals that a single dose of medicinal cannabis may decrease total sleep time and REM sleep in adults with insomnia, highlighting the need for further research into its effects on sleep health.

The Dangerous Dual Nature of Scopolamine: From Motion Sickness Treatment to Criminal Weaponization

Scopolamine, known as 'devil's breath,' is a medication for motion sickness but has been misused in crimes involving memory loss and assault. Learn about its risks and criminal implications.

FDA Grants Full Approval to Moderna's COVID-19 Vaccine for Certain Young Children

The FDA has fully approved Moderna's Spikevax COVID-19 vaccine for children aged 6 months to 11 years with specific health risks, marking a major milestone in pediatric vaccination efforts.

Loneliness Linked to Increased Risk of Hearing Loss: Insights from a Large UK Cohort Study

A large UK study uncovers a strong association between loneliness and increased risk of developing hearing loss, emphasizing the impact of social factors on ear health.